<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144516">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01219335</url>
  </required_header>
  <id_info>
    <org_study_id>RMA-00-02</org_study_id>
    <nct_id>NCT01219335</nct_id>
  </id_info>
  <brief_title>Discarded Materials Study</brief_title>
  <official_title>Evaluation of Non-viable Oocytes, Extra Spermatozoa, Developmentally Arrested Non-viable Embryos, Granulosa Cells, Serum, Follicular Fluid, and Conditioned IVF Media for Optimization of Laboratory Technology in Assisted Reproduction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reproductive Medicine Associates of New Jersey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reproductive Medicine Associates of New Jersey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of excess materials generally discarded in the process of undergoing IVF treatment to
      further develop and validate laboratory techniques.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1- Testing methods or freezing eggs and/or sperm before implementing techniques. 2- Develop
      cell surgery and micromanipulation techniques. 3- Develop methods to optimize the
      determinations of genes and chromosomes in embryos. 4- Quality-assess laboratory equipment.
      5- Test proficiency of laboratory staff. 6- Analyze what effects the early development of
      gametes and embryos. 7- Develop new methods and media to allow for higher survival rates of
      gametes and embryos. 8- Develop non-invasive tests for predicting oocyte and embryo quality
      to predict IVF success.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Methods for freezing sperm, eggs and/or embryos</measure>
    <time_frame>duration of the study</time_frame>
    <description>To test, standardize and implement better methods for the freezing of sperm, eggs, and/or embryos prior to these techniques being used in the clinical setting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Development non-invasive tests</measure>
    <time_frame>duration of the study</time_frame>
    <description>The use of discarded tissues such as granulosa cells, conditioned media etc. to develop non-invasive tests for predicting oocyte and embryo quality as well as IVF success</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Factors that control gametes and embryos</measure>
    <time_frame>duration of the study</time_frame>
    <description>To analyze gametes and embryos to learn more about what controls their early development and function.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Infertility</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Discarded non-viable oocytes, granulosa cells, spermatozoa, developmentally arrested
      embryos, serum, follicular fluid, and conditioned IVF media.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing infertility treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard T Scott, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Reproductive Medicine Associates of New Jersey</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine V Reda, BSN, RN</last_name>
    <phone>973-656-2841</phone>
    <email>clinicalresearchteam@rmanj.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Talia Metzgar, RN</last_name>
    <phone>973-656-2841</phone>
    <email>clinicalresearchteam@rmanj.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reproductive Medicine Associates of Connecticut</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine V Reda, BSN,RN</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@rmanj.com</email>
    </contact>
    <contact_backup>
      <last_name>Talia Metzgar, RN</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@rmanj.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Leondires, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reproductive Medicine Associates of new Jersey</name>
      <address>
        <city>Basking Ridge</city>
        <state>New Jersey</state>
        <zip>07920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine V Reda, BSN, RN</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@rmanj.com</email>
    </contact>
    <contact_backup>
      <last_name>Talia Metzgar, RN</last_name>
      <phone>973-656-2841</phone>
      <email>clinicalresearchteam@rmanj.com</email>
    </contact_backup>
    <investigator>
      <last_name>Richard T Scott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.rmanj.com</url>
    <description>Reproductive Medicine Associates of New Jersey</description>
  </link>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 16, 2017</lastchanged_date>
  <firstreceived_date>October 8, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IVF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
